TechNavio recognizes the following companies as the key players in the Pharmerging Markets: Abbott Laboratories, Amgen Inc., Astellas Pharma Inc., AstraZeneca plc, Bayer HealthCare AG, Boehringer Ingelheim Pharmaceuticals Corp., Bristol-Myers Squibb Co., Eisai Co Ltd., GlaxoSmithKline plc, Johnson & Johnson, Eli Lilly and Co., Merck & Co Inc., Novartis International AG, Novo Nordisk A/S, Pfizer Inc., Roche Holding Ltd., and Sanofi SA.
Commenting on the report, an analyst from TechNavio’s team said: “Partnership activities with vendors toward the development of new products especially generic drugs are increasingly being adopted by big pharmaceutical companies to sustain their presence in the Pharmerging markets. For example, Pfizer Inc. announced a partnership with Laboratório Teuto Brasileiro SA to develop and commercialize generic medicines in 2010. Another example includes Eli Lilly which expanded a strategic partnership with Chinese manufacturer Novast Laboratories Ltd. in 2011 to serve Chinese patients with high-quality generic medicines. Such partnership activities are expected to grow during the forecast period, boosting the Pharmerging markets.”
According to the report, one of the major drivers in this market is the increased healthcare spending. It was estimated that Pharmerging markets constitute about 20 percent of pharmaceutical spending and are expected to contribute 30 percent by 2016 of the Global Pharmaceutical market spending.
Further, the report states that one of the challenges in this market is the price pressure faced by the big pharmaceutical companies. Governments in the Pharmerging markets have developed policies that favor the local manufacturers. In order to market their products big pharmaceutical companies are forced to reduce their product prices to attract the local populace and government.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit https://www.technavio.com/report/pharmerging-markets-2012-2016
TechNavio, the market research platform of Infiniti Research Ltd., publishes periodic market research reports on niche and emerging technologies. For more information on our market research, please visit https://www.technavio.com/healthcare-chemicals-food-retail
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Research Report -Pharmerging Markets 2012-2016
